Skip to main content
    P

    Prime Medicine, Inc. Common Stock (PRME)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $3.84
    -0.35 (-8.35%)

    Market Cap: $932.06M

    Last updated: Nov 17, 2026 at 4:31 PM ET

    Prime Medicine, Inc. Common Stock (PRME) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Prime Medicine, Inc. Common Stock (PRME) has a latest price of $3.84 on Nov 17, 2026, 35.0% below its 52-week high of $5.91. Its price rose 13.9% over the past 12 months. The month-end price fell 27.3% over the 3 years through Oct 2026, a compound annual decline of 10.1%.

    Price Chart

    From Oct 2022 to Oct 2026, its highest month-end close was $18.82 in Oct 2022 and its lowest $1.18 in May 2025, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart PRME with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for PRME.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price rose 8.5%, and over 6 months it rose 42.2%.

    PeriodChange
    1 month+0.3%
    3 months+8.5%
    6 months+42.2%
    12 months+13.9%
    12 months, with dividends+13.9%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years-27.3%-10.1%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2025, when the price rose 18.8%, and its weakest was 2024, when it fell 67.0%.

    YearCloseChange
    2026 through Oct 2026$4.72+36.0%
    2025$3.47+18.8%
    2024$2.92-67.0%
    2023$8.86-52.3%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 3.4% above its 50-day average of $3.71 and 9.5% above its 200-day average of $3.51.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$3.84
    52-week high$5.91-35.0%
    52-week low$2.67+43.8%
    50-day average$3.71+3.4%
    200-day average$3.51+9.5%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 88.0%.

    MeasureValue
    1-year beta2.46
    Largest fall, 1 year-42.2%
    Largest fall, 3 years-88.0%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About PRME

    What is PRME's 1-year price change?

    Prime Medicine, Inc. Common Stock's price rose 13.9% over the past 12 months. With dividends included, the 12-month total return was 13.9%.

    How has PRME stock done over the long term?

    Prime Medicine, Inc. Common Stock's month-end price fell 27.3% over the 3 years through Oct 2026, a compound annual decline of 10.1%. These figures leave out dividends.

    What is PRME's 52-week high and low?

    Prime Medicine, Inc. Common Stock's 52-week high is $5.91 and its 52-week low is $2.67. Its latest price of $3.84 on Nov 17, 2026 is 35.0% below the high.

    What is PRME's beta?

    Prime Medicine, Inc. Common Stock's 1-year beta against the S&P 500 is 2.46, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 42.2%.

    Is the PRME chart free?

    Yes. Advanced Charting for PRME is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.